George Lawrence Mikan III Sells 12,440 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 12,440 shares of the firm’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $6.13, for a total value of $76,257.20. Following the transaction, the chief executive officer now owns 249,454 shares in the company, valued at approximately $1,529,153.02. This trade represents a 4.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

George Lawrence Mikan III also recently made the following trade(s):

• On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The shares were sold at an average price of $6.93, for a total value of $91,337.40.
• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total value of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Down 7.4 %

Shares of NYSE NEUE opened at $4.71 on Tuesday. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The company has a market cap of $38.98 million, a P/E ratio of -0.09 and a beta of 0.56. The business’s 50 day moving average is $7.21 and its two-hundred day moving average is $6.01.

Hedge Funds Weigh In On NeueHealth

A number of institutional investors and hedge funds have recently bought and sold shares of NEUE. Northern Trust Corp grew its position in NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares during the last quarter. Virtu Financial LLC acquired a new stake in NeueHealth during the fourth quarter worth about $76,000. Finally, Partners Group Holding AG acquired a new stake in NeueHealth during the third quarter worth about $463,000. Institutional investors own 63.88% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.